Reproof, Rebrand, Revalue. Executive Summary N4 Pharma - a UK-based pharma reformulation company with strong patents and proprietary technology which.

Slides:



Advertisements
Similar presentations
2008 Future Leaders Conference March 27 th, 2008 Millennium Hotel – New York.
Advertisements

Small Molecules for Better Sight March 2013 Company Presentation March 2013 Company Presentation.
Innovative Drug Delivery Solutions Innovative Drug Delivery Solutions IGXT-OTCBB IGXT-OTCBB 1 IntelGen x Technologies, Corp. November 2007 We make approved.
1 Heather Davis September 27, 2011 Ottawa, Canada Biotech to Big Pharma Personal Experience.
Chapter Sixteen Science, Technology, and Global Health.
Anti-Cancer Nanopods: Rational Design of an Oligoarginine Based Gene Delivery Vehicle Targeted to Hepatocarcinoma Kathy Y. Wei, Rob S. Burke, Suzie H.
GENE THERAPY.
DAVID HARDING CPhI 2008 SHANGHAI JUNE 24–26, 2008 Product Selection for API Manufacturers and Generic Pharmaceutical Companies: A Tool for Success.
SUCCESS FACTORS IN THE PHARMACEUTICAL MARKETPLACE
Industry Trends and Tools for Generic Product Selection KATE KUHRT SHANGHAI JUNE 19-21, 2007.
Critical Success Factors for the Korean Generic and API Industry in a post FTA Environment DAVID HARDING SEOUL JUNE 28-29, 2007.
Pharmaceutical Industry Analysis Nature of the industry: Highly defensive and 15% of U.S. population aged over 60→Highly mature. Main forces are the suppliers,
Cancer Vaccines Medicines that belong to a class of substances known as biological response modifiers. Biological response modifiers stimulate or restore.
VACCINATION. Vaccination: Is The administration of an antigen to stimulate a protective immune response against an infectious agent.
5 Summary Innovation Strategies
General classes of vaccines An induced mobilization of the immune response for the purpose of therapeutic benefit. Preventative: infectious agents Therapeutic:
Α-Interferon to Hepatitis B Lecturer: Sun fengkai Team members : Qixin Jiaming Songhaiyang Yulingqi Zhangwen Zhaoliang.
Gene Therapy. What is Gene Therapy? Defective genes make non-functional proteins, creating genetic disorders Gene therapy corrects defective genes by.
Enter the Title of Your Presentation Lead Inventors Name Other Inventors Name Purpose: Enter why you are coming to patent committee (initial filing, PCT,
4 Molecular biology in medicine Figure 4.1 The influenza virus has two surface proteins: neuraminidase and haemagglutinin. These proteins change continually,
Drug Delivery and Generic Medicine The Challenge ahead; Choose where to play. MENA as an Industry Model Mohammad Refaat Khattab Cairo University; Egypt.
1 Global Health Research How the private sector contribute Bergen, 22. September 2004 Birger Sørensen, President CEO Bionor Immuno AS.
Patents and Medicines: How the system has discouraged innovation and reduced patient access to benefits of knowledge GREG PERRY Director General, EGA World.
Global Recognition of the Indian Biotech Sector - The Road Ahead Sept 26,2003 Hyderabad.
Method of Administering Medication Kevin Murphy. Administration Methods One way to administer a drug is to taking it orally either by pills, capsules,
Viruses are the smallest infectious diseases (ranging from nm) They are obligatory intracellular parasites without own metabolism (being parasites.
Lecture #9 Date______ Chapter 21~ The Genetic Basis of Development.
Browse more reports on Pharmaceuticals at sciences/pharmaceuticalshttp://
BIOTECHNOLOGY.
New Technologies: the Role of the Private Sector Biotech’s Perspectives on Vaccine Development Alliances Peter Young CEO, AlphaVax, Inc.
The Pharmaceutical Composition Methodology described in this presentation has been developed to improve controlled drug delivery through site specific.
Histone Methyltransferases: Global Industry Report for Research Tools, Diagnostics and Drug Discovery
Industry’s Perspective on Industry-University Intellectual Property External Research Directors Network Industrial Research Institute, Inc. April 17, 2001.
Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners.
SEEK is a drug-discovery group that uses a pioneering scientific and commercially-driven approach to create breakthrough medicines which address major.
Nanomedicine - Medicine of the future. Medical application of nanotechnology – Nanotechnology: the study of the control of matter at the atomic/molecular.
Genetics of Viruses. Viral Structure n Virus: – “poison” (Latin) – infectious particles consisting of a nucleic acid in a protein coat n Capsid= viral.
Genetic DNA Vaccines By Chelsea Heimbrock. What are DNA Vaccines? An injection of genes of a virus into the body that creates an immune response for the.
Gene therapy Lecture 8. What is a liposome? ◦ Spherical vesicles with a phospholipid bilayer Hydrophilic Hydrophobic.
AktieTorgets investerarfrukost 17 september 2015 David Westberg, CEO.
Targeted Drug Therapeutics An overview of our technologies and their potential 505(b)(2) applications Sino-American Regulatory Consulting Alliance Yongtian.
Building a bioscience business in Cheshire Dr John Ridden CEO and Co-Founder 26 th June 2014.
World Enzymes Market – Opportunities and Forecasts, Published: Sept 2015 No of Pages: 133.
Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV   USA Telephone   Fax   
Irina Callens 18/06/2015 EXPRESSION AND ROLE OF A CYPRINID HERPESVIRUS-3 MICRORNA.
Cognitive Impairment Associated With Schizophrenia (CIAS)Pipeline Review, H Published on : October No. Pages : 110.
Aarkstore - Metastatic Ovarian Cancer- Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Category : Pharmaceuticals and Healthcare.
Five Prime Therapeutics, Inc. Product Pipeline Review Published on : October No. Pages : 44.
Ramping Up Flu Vaccine Efforts
VIRUSES. STRUCTURE How viruses infect – FUNCTION of a virus (double click below)
Lipofection (or liposome transfection) is a technique used to inject genetic material into a cell by means of liposomes, which are vesicles that can easily.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
Developing and Broadening Specialists in Research & Development
Vaccine Company Perspective Dr Gaurav Gupta, ZYDUS CADILA
Products > Pancreas In Vivo Transfection Kit
Initial Market Assessment
KJ Hansen, JK Simons, TA Peterson
Immune System Basics Immunity: The capacity to resist infectious pathogens. Pathogens: Disease-causing organisms Self vs. Non-self recognition Major Histocompatibility.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Preventive and Therapeutic.
Immunology & Public Health
TEKS 4.C Students will… Compare the structure of viruses to cells, describe viral reproduction, and describe.
Novel vaccine adjuvants for infectious diseases aninal
Surface-Engineered Gold Nanorods: Promising DNA Vaccine Adjuvant for HIV-1 Treatment Jihui Lee OCT 25, 2016.
Viruses & Bacteria 1.
Rate of Reaction.
Unit 4 - Immunology and Public Health
Croatia, Zagreb, September 4, 2018 Ljiljana Sović Brkičić
Moving Cellular Material
Zika Virus: Immunity and Vaccine Development
VACCINATION. Vaccination: Is The administration of an antigen to stimulate a protective immune response against an infectious agent.
Presentation transcript:

Reproof, Rebrand, Revalue

Executive Summary N4 Pharma - a UK-based pharma reformulation company with strong patents and proprietary technology which it uses to revitalise and revalue existing drugs lead product is an improved version of Sildenafil (Viagra); faster onset of action with effective level of drug maintained in its therapeutic window from dose to dose. Exclusive global rights to two proprietary vaccine delivery platforms for sub unit vaccines, messenger RNA and plasmid DNA molecules. N4 maintains strong intellectual property portfolio and is funded by AIM listed investment company Onzima Ventures Plc Setting up Special investment vehicles for its reformulated Viagra, vaccines and other new product reformulation opportunities –Each opportunity with blockbuster potential 2

Strong Intellectual property 3 N4 has 4 platform technologies allowing reformulation and improvement of a wide range of existing drugs OPAL IPCocrysNuvacNuvec Wide range of patents drafted by ex GSK head of patents Patent from Bradford University to manufacture cocrystals using Hot Melt extrusion Silica nano particles designed to improve sub unit vaccines Silica nano particle delivery platform for mRNA and pDNA molecules

Strong Intellectual property 4 N4 has 4 platform technologies allowing reformulation and improvement of a wide range of existing drugs OPAL IPCocrysNuvacNuvec Wide range of patents drafted by ex GSK head of patents Patent from Bradford University to manufacture cocrystals using Hot Melt extrusion Silica nano particles designed to improve sub unit vaccines Silica nano particle delivery platform for mRNA and pDNA molecules 45 patents filed for Improved version of sildenafil Novel cocrystals of sildenafil Single dose Hepatits B vaccine Novel vector for improved mRNA and pDNA protection and transfection Sub unit vaccines for rare diseases, zika, dengue, lassa, ebola and many others

Improved Viagra (combined OPAL & Cocrys) 5 Viagra (sildenafil) formulated for different use to current indication –Developed as cardio drug before erectile dysfunction discovered –As a consequence it takes one hour before drug takes effect –4 hour half life –Use needs careful planning Viagra “Plus” –Fast onset of action but also longer lasting –Therapeutic window maintained dose to dose

Improved Viagra (combined OPAL & Cocrys) 6 Viagra off patent most countries and facing strong competition Pfizer switching Viagra over the counter N4 filed 45 patents for improved Sildenafil - incredibly strong IP protection Global market size for erectile dysfunction $4.5bn Viagra (sildenafil) formulated for different use to current indication –Developed as cardio drug before erectile dysfunction discovered –As a consequence it takes one hour before drug takes effect –4 hour half life –Use needs careful planning Viagra “Plus” –Fast onset of action but also longer lasting –Therapeutic window maintained dose to dose

Cocrys ™ Patented process to use Hot Melt extrusion to produce co-crystals 7 Insoluble drug (Viagra) is combined with a co-former to alter its rate of dissolution

Cocrys ™ Patented process to use Hot Melt extrusion to produce co-crystals 8 Insoluble drug (Viagra) is combined with a co-former to alter its rate of dissolution The drug and co-former are blended together and temperature and sheer are used to fuse them together at their interface to create co-crystals of the drug. Resultant co-crystals are stable due to their strong bond and can be commercially manufactured using continuous batch production.

Nuvac® Nano silica particles with high surface area:volume ratio 9

Nuvac® Nano silica particles with high surface area:volume ratio –Imagine practise golf balls, nuvac controls the pore size to allow antigen loading inside the vesicle and delayed release of the antigen 10

Nuvac® Nano silica particles with high surface area:volume ratio –Imagine practise golf balls, nuvac controls the pore size to allow antigen loading inside the vesicle and delayed release of the antigen Resulting immune reaction is immediate and long lasting removing the need for repeat doses –Single injection to maintain immunity –Natural adjuvant, no need for Alum –Thermally stable 11

Nuvec™ Nano silica particles designed to look like a rambutan fruit 12

Nuvec™ Nano silica particles designed to look like a rambutan fruit Allows pDNA and mRNA to hook to the silica spikes 13

Nuvec™ Nano silica particles designed to look like a virus –Allows pDNA and mRNA to hook to the silica spikes Vector plays dual role –protects the molecule on its pathway to the cell –Good cellular transfection observed 14

Nuvec™ Nano silica particles designed to look like a virus –Allows pDNA and mRNA to hook to the silica spikes Vector plays dual role –protects the molecule on its pathway to the cell –Good cellular transfection observed –Nuvec can be optimised for safe and effective delivery of pDNA and mRNA to targeted cancer cells 15

Summary 16 Strong intellectual property Company individual special investment vehicle opportunities –Investments ranging from £2m to £10m+ Improved Viagra alone worth over £250m Immediate investment opportunities for –Improved Sildenafil –Single dose Hepatitis B –Rare disease single dose sub unit vaccines –pDNA and mRNA delivery vectors